Zobrazeno 1 - 10 of 66 pro vyhledávání: '"Yume, Nagaoka"'
4
The effect of small dose of topiroxostat on serum uric acid in patients receiving hemodialysis
Autor: Mio Ueda, Minako Akiyama, Shinnichi Iwai, Miho Nagai, Eiichiro Kanda, Yume Nagaoka, Yoshihiko Kanno, Michio Nagaoka, Rie Suzuki, Kakei Ryu, Yoshitaka Miyaoka, Yoshiko Tanaka, Hiroshi Yoshimoto
Publikováno v: Hemodialysis International. 22:388-393
Introduction: Topiroxostat, a recently developed xanthine oxidase inhibitor, is expected to have fewer adverse effects than allopurinol because it has different mechanism of action from alloprinol. However, its dosage, usage and safety have not been
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::50f3d24543183ebe2cdeb34309cc8430
https://doi.org/10.1111/hdi.12620
Zobrazit plný text záznamu
6
Evaluation of the efficacy of granulocyte and monocyte adsorption apheresis on skin manifestation and joint symptoms of patients with pustulotic arthro-osteitis
Autor: Hirofumi Hirano, Yuka Matsumoto, Yume Nagaoka, Ryoji Tsuboi, Yukari Okubo, Namiko Abe, Yoshihiko Kanno, Hiroshi Kawakami
Publikováno v: The Journal of dermatology. 46(2)
Pustulotic arthro-osteitis, occasionally complicated with palmoplantar pustulosis, affects patients' activities of daily living. Granulocyte and monocyte adsorption apheresis selectively removes activated granulocytes and monocytes by means of extrac
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d64ce77c902984aef7aaeb2b6d96bdbf
https://pubmed.ncbi.nlm.nih.gov/30549087
Zobrazit plný text záznamu
7
Association between visit-to-visit clinic blood pressure variability and home blood pressure variability in patients with chronic kidney disease
Autor: Toshikazu Wada, Tomonari Okada, Yume Nagaoka, Yoshihiko Kanno
Publikováno v: Renal Failure. 37:446-451
Although both clinic blood pressure (BP) variability and home BP variability are associated with the risk of cardiovascular disease, the relationship between both BP variabilities remain unclear. We evaluated the association between visit-to-visit va
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c90e3f22bb424a755e7e0db5b4a134e2
https://doi.org/10.3109/0886022x.2014.996730
Zobrazit plný text záznamu
8
The effect of small dose of topiroxostat on serum uric acid in patients receiving hemodialysis
Autor: Yume, Nagaoka, Yoshiko, Tanaka, Hiroshi, Yoshimoto, Rie, Suzuki, Kakei, Ryu, Mio, Ueda, Minako, Akiyama, Miho, Nagai, Yoshitaka, Miyaoka, Eiichiro, Kanda, Shinnichi, Iwai, Michio, Nagaoka, Yoshihiko, Kanno
Publikováno v: Hemodialysis international. International Symposium on Home Hemodialysis. 22(3)
Topiroxostat, a recently developed xanthine oxidase inhibitor, is expected to have fewer adverse effects than allopurinol because it has different mechanism of action from alloprinol. However, its dosage, usage and safety have not been established in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e3a130eacddfd02b2e84617c8b58ad32
https://pubmed.ncbi.nlm.nih.gov/29227568
Zobrazit plný text záznamu
10
Clinical significance of microscopic haematuria in diabetic nephropathy in type 2 diabetes patients with overt proteinuria
Autor: Yume Nagaoka, Toshitaka Nagao, Tomonari Okada, Toshikazu Wada, Toshiyuki Nakao, Hiroshi Matsumoto
Publikováno v: Nephrology. 18:563-568
Aim Although some patients with diabetic nephropathy with overt proteinuria have microscopic haematuria, the pathological characteristics and clinical significance related to microscopic haematuria have not yet been clarified. The aim of the present
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::eda5260aa1bef0a3e585610c6699c26a
https://doi.org/10.1111/nep.12104
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje